These are important details that the Medicines and Healthcare products Regulatory Agency (MHRA) always considers when assessing candidate vaccines for use.
For this vaccine, like lots of others, they have identified that some people might feel slightly unwell, but they report that no significant side effects have been observed in the more than 43,000 people involved in trials.
All patients will be provided with information on the vaccine they have received, how to look out for any side effects, and what to do if they do occur, including reporting them to the MHRA.
More information on possible side effects can be found here (opens in a new window)